FDA/NIH advocate, House 'Dean' John Dingell to depart Congress
This article was originally published in Scrip
With the departure of Representative John Dingell (Democrat-Michigan) – the longest serving member of Congress, who revealed on 24 February he does not plan to run for re-election at the end of this year – the FDA, the National Institutes of Health (NIH) and American healthcare in general are losing another advocate on Capitol Hill who has not only pushed for more funding for the health and science agencies, but has been behind some of the key pieces of legislation that have affected them the most.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.